Articles related to HEART FAILURE (HF)

Melatonin supplements are widely thought of as a safe and ‘natural’ option to support better sleep, so it was striking to see such consistent and significant increases in serious health outcomes, even after balancing for many other risk factors.

HFpEF and HFmrEF collectively account for up to 75% of all heart failure cases, yet clinical research and treatment evidence in HFpEF and HFmrEF is substantially limited compared with other types of heart failure.

HF was independently associated with a 30% to 50% higher IS rate in 2007 to 2010, but this association attenuated to only 10% to 15% higher in 2015 to 2018.

Age-adjusted mortality data reveals remarkable therapeutic success in acute ischemic events while highlighting emerging challenges in chronic cardiovascular conditions requiring enhanced primary care management strategies.

Four-month mitoquinone supplementation reversed early indicators of cardiac metabolic stress in Type 2 diabetes patients, improving heart energy efficiency by 15% compared to standard treatment alone.

First randomized evidence supporting feasibility of maintaining cardiac stability with carvedilol alone after systematic withdrawal of other heart failure medications in selected patients.